The leading board of Antibiotics Sa
revealed yesterday the business plan of the company for the next 4 years, 2008-2012, showing that, with or without the privatization
, the pharmaceutical enterprise goes ahead. It has been estimated an economical growth and a profit from 10.9 millions euro in 2008 to 29.4 millions in 2012.
Site-ul bzi.ro nu raspunde pentru opiniile postate in rubrica de comentarii, responsabilitatea formularii acestora revine integral autorului comentariului.